X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
humans (8) 8
animals (5) 5
liposomal prostaglandin e1 (4) 4
male (4) 4
pharmacology & pharmacy (4) 4
aged (3) 3
alprostadil - therapeutic use (3) 3
analysis (3) 3
cancer (3) 3
drug delivery systems (3) 3
female (3) 3
middle aged (3) 3
percutaneous coronary intervention - methods (3) 3
acute lower limb ischemia (2) 2
alprostadil - administration & dosage (2) 2
antineoplastic agents - administration & dosage (2) 2
articles (2) 2
biochemistry & molecular biology (2) 2
cardiovascular diseases (2) 2
care and treatment (2) 2
chemistry, multidisciplinary (2) 2
drug carriers - chemistry (2) 2
e-1 (2) 2
health aspects (2) 2
heart attacks (2) 2
human osteosarcoma xenografts (2) 2
hybrid procedures (2) 2
interstitial fluid pressure (2) 2
lipids (2) 2
liposomal prostaglandin e (2) 2
management (2) 2
medicine, general & internal (2) 2
microcirculation - drug effects (2) 2
neoplasms - drug therapy (2) 2
neoplasms - metabolism (2) 2
pegylated liposomal doxorubicin (2) 2
pegylated-liposomal doxorubicin (2) 2
percutaneous coronary intervention (2) 2
prostaglandins e (2) 2
reperfusion injury (2) 2
studies (2) 2
surgery (2) 2
tumor microenvironment (2) 2
vasodilator agents - therapeutic use (2) 2
3400 (1) 1
abridged index medicus (1) 1
accelerated blood clearance (1) 1
accelerated blood clearance phenomenon (1) 1
acute lung injury (1) 1
acute respiratory distress syndrome (1) 1
administration, intravenous (1) 1
algorithms (1) 1
alprostadil (1) 1
alprostadil - metabolism (1) 1
alprostadil liposomal preparation (1) 1
amikacin (1) 1
amphotericin b (1) 1
angina (1) 1
angina, unstable - therapy (1) 1
angioplasty (1) 1
ankle brachial index (1) 1
anti (1) 1
anti-peg igm (1) 1
anticoagulants (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic agents - therapeutic use (1) 1
antitumor-activity (1) 1
application (1) 1
article (1) 1
b cells (1) 1
bioavailability (1) 1
biochemistry, general (1) 1
biodegradability (1) 1
biointerfacial interactions (1) 1
biological availability (1) 1
biomarkers - blood (1) 1
biomedicine (1) 1
biomedicine general (1) 1
biophysics (1) 1
biophysics and biological physics (1) 1
biotechnology (1) 1
biotechnology & applied microbiology (1) 1
bladder (1) 1
blood (1) 1
blood-brain-barrier (1) 1
blood-vessels (1) 1
blue toe syndrome (1) 1
blue toe syndrome - drug therapy (1) 1
c-reactive protein - immunology (1) 1
cancer-associated fibroblasts (1) 1
cardiac & cardiovascular systems (1) 1
cardiac patients (1) 1
cardiac surgical procedures - adverse effects (1) 1
cardiac surgical procedures - methods (1) 1
cardiology (1) 1
cardiotonic agents - administration & dosage (1) 1
carriers (1) 1
cell biology (1) 1
cell-penetrating peptides (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Coronary Artery Disease, ISSN 0954-6928, 12/2015, Volume 26, Issue 8, pp. 671 - 677
Journal Article
中华医学杂志:英文版, ISSN 0366-6999, 2015, Volume 128, Issue 9, pp. 1147 - 1150
Background:Several studies have demonstrated that primary percutaneous coronary intervention (PCI) can result in reperfusion injury.This study aims to... 
微循环 | ST | 介入治疗 | 静脉给药 | 前列腺素E1 | 急诊 | 心肌梗死 | 患者 | Primary percutaneous coronary intervention | ST Elevation myocardial infarction | Intravenous administration | Liposomal prostaglandin E1 | Liposomal Prostaglandin E1 | SEGMENT ELEVATION | Intravenous Administration | NO-REFLOW PHENOMENON | NICORANDIL | MODEL | INTRACORONARY ADENOSINE | MEDICINE, GENERAL & INTERNAL | Primary Percutaneous Coronary Intervention | FRAME COUNT | THROMBOLYSIS | ST Elevation Myocardial Infarction | MICROVASCULAR REPERFUSION INJURY | PRIMARY ANGIOPLASTY | CORONARY INTERVENTION | Administration, Intravenous | Myocardial Infarction - drug therapy | Alprostadil - therapeutic use | Percutaneous Coronary Intervention - methods | Humans | Middle Aged | Female | Male | Aged | Microcirculation - drug effects | Alprostadil - administration & dosage | Prevention | Care and treatment | Prostaglandins E | Cardiac patients | Dosage and administration | Research | Reperfusion injury | Heart failure | Performance evaluation | Heart attacks | Medical imaging | Laboratories | Angioplasty | Studies | Hospitals | Coronary vessels | Rodents | Electrocardiography | Intubation | Cardiology | Veins & arteries | Original | Intravenous Administration; Liposomal Prostaglandin E1; Primary Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction
Journal Article
Experimental and Therapeutic Medicine, ISSN 1792-0981, 06/2013, Volume 5, Issue 6, pp. 1760 - 1764
Journal Article
Critical Care Medicine, ISSN 0090-3493, 08/1999, Volume 27, Issue 8, pp. 1478 - 1485
OBJECTIVETo evaluate the safety and efficacy of an intravenous liposomal dispersion of prostaglandin E1 as TLC C-53 in the treatment of patients with acute... 
Acute respiratory distress syndrome | Acute lung injury | Neutrophils | Liposomal prostaglandin E | Liposomes | Prostaglandin E | Oxygenation | Mechanical ventilation
Journal Article
by Li, JL and Wang, B and Wang, Y and Wu, F and Li, PF and Li, Y and Zhao, L and Cui, WJ and Ding, Y and An, Q and Si, JT
EXPERIMENTAL AND THERAPEUTIC MEDICINE, ISSN 1792-0981, 06/2013, Volume 5, Issue 6, pp. 1760 - 1764
Prostaglandin E-1 (PGE(1)) is widely used in the treatment of limb ischemia for its potent vasodilatory and antiplatelet effects. In order to assess the... 
MEDICINE, RESEARCH & EXPERIMENTAL | IMPROVES | hybrid procedures | acute lower limb ischemia | MANAGEMENT | liposomal prostaglandin E-1
Journal Article
Drug Delivery System, ISSN 0913-5006, 2008, Volume 23, Issue 4, pp. 460 - 466
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 02/2016, Volume 97, pp. 280 - 301
Journal Article
Expert Opinion on Drug Delivery, ISSN 1742-5247, 09/2015, Volume 12, Issue 9, pp. 1475 - 1499
Journal Article